Responses
Hepatology
Original article
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B
Compose a Response to This Article
Other responses
No responses have been published for this article.